Dendrite Clinical Systems is pleased to announce the prestigious journal, Obesity Surgery, has published a paper highlighting international bariatric surgery practice from the 4th Dendrite/IFSO Global Registry Report. The paper, ‘Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth Dendrite/IFSO Global Registry Report 2018’, (Himpens et al. Obesity Surgery. March 2019.
Dendrite Clinical Systems and The State of Kuwait Ministry of Health,
Dendrite Clinical Systems and The American Vein and Lymphatic Society (formerly the American College of Phlebology) are delighted to announce the launch of the American Vein and Lymphatic Society Registry - a ‘real-time’ clinical database that will identify practice patterns for venous and lymphatic disease diagnosis and treatment across North America.
Dendrite Clinical Systems and the Society for Cardiothoracic Surgery in the UK are pleased to announce the SCTS Conference News 2019 newspaper is now available to view/download. This is the fourth successive year Dendrite has published the newspaper on behalf of the SCTS. The newspaper reports a multitude of presentations from the meeting including the latest and the best information on new technologies and techniques in cardio-thoracic surgery. 
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 39 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
Dendrite Clinical Systems in pleased to announce its clinical database system has been selected to collect, record and analyse data from the Obesity Research Biobank Syndicate (ORBiS) Registry. ORBiS is a network of multidisciplinary professionals working towards a common goal: to gain novel insights into obesity and weight management, and help translate these findings into improved patient care. 
UK-ROPE outcomes demonstrate value of registries
The positive outcomes from the UK-ROPE (Registry of prostate embolization) – a collaboration initiated by British Society of Interventional Radiology (BSIR) and Dendrite Clinical Systems – has resulted in a National Institute of Health and Care Excellence (NICE) recommendation that prostate artery embolization (PAE) should be made available by the NHS. The registry was jointly funded by the National Institute of Health and Care Excellence (NICE), the British Society of Interventional Radiology (BSIR), the British Association of Urological Surgeons (BAUS) and Cook Medical.
UK-ROPE utilised Dendrite’s unique ‘Intellect Web’ national registry software to facilitate on-line data entry. The Registry was accessed using a range of modern html-5 compatible web browsers, allowing registrants to enter data securely without the need to install additional software or perform any complex system configurations.
“I would like to congratulate the investigators of ROPE on the outcomes of the registry,” said Dr Peter Walton, Managing Director of Dendrite Clinical Systems. “The outcomes from ROPE and recommendation by NICE again demonstrates the power of ‘real world’ data from clinical registries.”
Prostate artery embolization or benign prostatic hyperplasia (BPH) is used to treat non-cancerous enlargement of the prostate, a very common condition in older men, and blocks some of the blood supply to the prostate using tiny synthetic beads, causing the troublesome tissue to shrink and die, and importantly, spares patients from undergoing surgery and potential side-effects such as impotence.
When compared directly with a matched cohort of men undergoing transurethral resection of the prostate (TURP), patients who underwent embolization had less hospital stay, fewer erectile function problems, improved urinary flow and an average reduction of prostate size of nearly 30%.
"It (PAE) is a particularly good option for men who are not yet ready to undergo more invasive prostate surgery. Maintaining sexual function and fertility is one of its main strengths,” Dr Nigel Hacking, Chairman & clinical lead for the UK-ROPE Standing Committee and consultant interventional radiologist at University Hospital Southampton, told the BBC. "I hope with NICE's recommendations, that more centres will be able to introduce PAE services in the not too distant future."
Since 1993, Dendrite Clinical Systems has been developing specialist clinical databases, analysis software, consultancy and publishing services that empower the international healthcare sector with the data they need. The company now has two offices in the UK and agents across four continents, and has expanded its global user base across hundreds of hospitals, with over 170 national and international registries in more than 40 countries.
